Not Yet Recruiting
The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment
NCT06810492
- Conditions
- Breast Cancer Stage II, Breast Cancer Stage III, Breast Diseases, +5 more
- Locations
-
Not specified